Improving Lives Through Biomedical Innovation

Paragon Biosciences is an incubator and investor that builds and grows leading biotechnology companies. We help people live longer, healthier lives.


Our Focus

At Paragon Biosciences our philosophy is simple: start with what the patient needs, understand the science behind the disease and then build companies completely focused on addressing unmet needs. That is what drives our successful model of rational drug development which helps speed the approval of important medicines. More than 6,000 diseases today that do not have a treatment available. We will make that number smaller, and help patients live longer, better lives.

Problems people have deemed unsolvable are the problems we are solving.

Our Companies

We develop companies with disciplined, targeted strategies that address specific clinical areas. 


Castle Creek

Castle Creek Pharmaceuticals (CCP), part of the Paragon Biosciences portfolio of innovative biotech companies, is a privately held biopharmaceutical company developing innovative therapies for patients with rare, serious or debilitating dermatologic conditions. The company has a robust and diversified pipeline of late-stage products that have the potential to transform lives. For more information, please visit


Harmony Biosciences

Harmony Biosciences is a biopharmaceutical company focused on identifying, developing, obtaining regulatory approval, and commercializing high-potential, innovative drugs to address unmet needs for patients with sleep and central nervous system (CNS) disorders. For more information, please visit



Decade is a research and development company focused on novel Alzheimer’s disease therapeutics that will fundamentally improve patient outcomes and quality of life.


Precision BP

Precision is a research and development driven organization focused on developing complex treatments in rare genetic oncology diseases.


Pipelines of Paragon Companies

We have a diverse pipeline of investigational drugs in four therapeutic areas being tested in clinical trials across our family of companies. 


Our Process

We pride ourselves on creating opportunities where other companies do not. We embrace and overcome challenges to deliver important medicines for patients in need.


Our Responsibility

We believe it is our responsibility to contribute to organizations which improve the human experience, both globally and locally.


Latest News


Jan 3, 2018

Castle Creek Pharmaceuticals to Participate in 5th Annual Dermatology Summit

Read More

Oct 27, 2017

Castle Creek Pharmaceuticals Receives Partners in Progress Award from debra of America

Read More

Oct 5, 2017

Harmony Biosciences Acquires US Rights To Pitolisant From Bioprojet; Raises $270 Million In Equity Financing

Read More